iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium
Business Wire•20/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.